Literature DB >> 8518910

Oestrogen and progesterone receptors in colorectal cancer and human colonic cancer cell lines.

C W Hendrickse1, C E Jones, I A Donovan, J P Neoptolemos, P R Baker.   

Abstract

Receptors for oestrogen (ER) and progesterone (PR) were assayed in tissue from 17 patients with colorectal cancer and five colonic cancer cell lines using enzyme immunoassays. ERs and PRs were detected in 15 and 17 cancers respectively, although the levels detected were low: median (range) ER 1.3 (0-11.3) and PR 3.9 (0.3-10.2) fmol per mg protein. These values were not significantly different from median (range) levels of ER (1.1 (0.6-3.0) fmol/mg) and PR (1.9 (0.5-3.2) fmol/mg) detected in normal mucosa. There were significant positive correlations between the levels of ER and PR for cancer tissue (tau = 0.56, P < 0.005; r(log transform) = 0.68, P < 0.003; n = 17) but not for mucosa, and between levels of ER in cancer tissue and mucosa (tau = 0.55, P < 0.05; r(log transform) = 0.70, P < 0.025; n = 10) but not between the corresponding PR values. In maintenance media, which contained phenol red and unstripped fetal calf serum, the median (range) concentration of ER was 1.9 (1.2-10.4) fmol/mg and that for PR 24.3 (9.1-63.2) fmol/mg in the five cell lines studied (HT-29, LS174T, SW620, LoVo, COLO 320DM). The addition of oestradiol (10 nmol/l) to phenol red-free medium containing 5 per cent dextran-coated charcoal-treated fetal calf serum had little effect on the concentration of ERs or PRs in SW620, LoVo and COLO 320DM cells after 7 days' culture. It is concluded that ERs and PRs are expressed in malignant and normal colonic mucosa. ERs appear to be a feature of the colonic mucosa rather than the malignant process, but in carcinoma may regulate synthesis of PRs, suggesting a degree of oestrogen responsiveness.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8518910     DOI: 10.1002/bjs.1800800531

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  20 in total

1.  Differential regulation of intestinal efflux transporters by pregnancy in mice.

Authors:  Jamie E Moscovitz; Gabriel Yarmush; Guadalupe Herrera-Garcia; Grace L Guo; Lauren M Aleksunes
Journal:  Xenobiotica       Date:  2017-01-03       Impact factor: 1.908

2.  Do the progesterone receptors have a role to play in gallbladder cancer?

Authors:  V Baskaran; U Vij; P Sahni; R K Tandon; S Nundy
Journal:  Int J Gastrointest Cancer       Date:  2005

3.  Reproductive history and risk of colorectal cancer in postmenopausal women.

Authors:  Alice Zervoudakis; Howard D Strickler; Yikyung Park; Xiaonan Xue; Albert Hollenbeck; Arthur Schatzkin; Marc J Gunter
Journal:  J Natl Cancer Inst       Date:  2011-03-29       Impact factor: 13.506

Review 4.  Oestrogen and colonic epithelial cell growth.

Authors:  S Singh; M J Langman
Journal:  Gut       Date:  1995-12       Impact factor: 23.059

5.  Vitamin D and estrogen receptor gene polymorphisms and the risk of colorectal cancer in Bulgaria.

Authors:  Tanya Kadiyska; Toma Yakulov; Radka Kaneva; Dimitar Nedin; Alexandrina Alexandrova; Antonina Gegova; Alexey Savov; Vanio Mitev; Ivo Kremensky
Journal:  Int J Colorectal Dis       Date:  2006-06-21       Impact factor: 2.571

6.  Immunohistochemical expression of estrogen and progesterone receptors in human colorectal adenoma and carcinoma using specified automated cellular image analysis system: a clinicopathological study.

Authors:  Ban Jumaa Qasim; Hussam Hasson Ali; Alaa Ghani Hussein
Journal:  Oman Med J       Date:  2011-09

7.  Estrogen controls expression and bioresponse of 1,25-dihydroxyvitamin D receptors in the rat colon.

Authors:  B Schwartz; P Smirnoff; S Shany; Y Liel
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

8.  Estrogen receptor hormone agonists limit trauma hemorrhage shock-induced gut and lung injury in rats.

Authors:  Danielle Doucet; Chirag Badami; David Palange; R Paul Bonitz; Qi Lu; Da-Zhong Xu; Kolenkode B Kannan; Iriana Colorado; Rena Feinman; Edwin A Deitch
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

9.  Sex hormone-receptor-negative tumors have a higher proliferative activity than sex hormone-receptor-positive tumors in human adenocarcinomas of the gastrointestinal tract.

Authors:  D Korenaga; H Orita; T Okuyama; J Kinoshita; S Maekawa; T Ikeda; K Sugimachi
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

10.  Menopausal hormone therapy and risk of colorectal cancer.

Authors:  Jill R Johnson; James V Lacey; Deann Lazovich; Melissa A Geller; Catherine Schairer; Arthur Schatzkin; Andrew Flood
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.